WeightWatchers (WW International) saw its stock price surge following the release of its second-quarter results and the reinstatement of its full-year outlook. The company attributed the positive performance to increased subscriptions driven by its embrace of weight-loss drugs. This strategic shift appears to be revitalizing the brand and attracting new customers. The market is reacting favorably to WeightWatchers' proactive approach in adapting to the evolving landscape of weight management solutions and integrating pharmaceutical options into its offerings.